Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/56d90f95-88cc-4244-aa4a-01a32bf62238/
ALA
Arovella Therapeutics LimitedSnapshot 2026-07-19 · 1.1w · Fresh
Strategy Eligibility
0 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
7.0%ile
P/S
577.8×
P/B
3.9×
FCF Yield
-0.127
SH Yield
-0.198
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
93.00000000
/100 — 1=cheapest
VC2 (Trending Value)
95.00000000
/100
VC3 (Buyback)
95.00000000
/100
Negative FCF yield (-12.7%) — the business is currently cash-consumptive. VC2 score of 95.00000000/100 — expensive across all six composite measures.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
81.0%ile
ROE
-0.374
ROA
-0.348
Net Margin
-55.214
Op Margin
-82.373
GPA
0.006
Current
14.18
F-Score
3/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
7.000
5yr Consist
No
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
5.0%ile
6M Return
-27.0%
12M Return
-38.1%
12-1 Mom
-32.4%
Risk-Adj
-0.59
Vol 252d
54.9%
Vol 60d
127.1%
↑ Expanding
Max DD 12M
-40.9%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of -32% signals a downtrend — price is moving against you. Near-term vol (127%) is expanding vs long-term (55%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.13
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare
· 145 peers
Sector Value %ile
15.8%
Sector Quality %ile
87.0%
P/B z-score
-0.28
Sector Avg OS
45.4%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
Factor Interactions
Quality at a Premium
High quality (81th) but expensive (7th value). Upside may be limited without earnings growth.
Volatility Expanding
60-day vol (127%) significantly exceeds 252-day (55%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
13.6% avg (4 factors)
Quality
F
16.9% avg (6 factors)
Momentum
F
3.5% avg (4 factors)
Risk
F
25.2% avg (1 factors)
Momentum is weak, suggesting the market isn't yet buying this thesis. Patience required. Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends7 snapshots
Factor Persistence7 snapshots
| Factor | Current | Streak | Trend | Spark |
|---|---|---|---|---|
| OS Composite | 0.130 | —7 | — | |
| Value %ile | 0.070 | —7 | — | |
| Quality %ile | 0.810 | —2 | — | |
| Momentum %ile | 0.050 | —7 | — | |
| F-Score | 3.000 | —7 | — | |
| Confidence | 0.362 | —6 | — | |
| Volatility | 0.549 | —7 | — |
Value Lens2021-07-20 → 2026-07-19
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
Price / Sales
577.76
Price / Book
3.91
FCF Yield
-12.7%
Sales Yield (1/P·S)
0.0024
Shareholder Yield
Div + net buyback / mktcap
-19.8%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
-37.4%
Return on Assets
-34.8%
Net Margin
-5521.4%
Operating Margin
-8237.3%
Gross Profit / Assets
Novy-Marx GPA
0.6%
Current Ratio
14.18
External Financing
Net issuance — lower=better
0.838
MomentumPrice trend strength over different horizons
6M Return
-27.0%
12M Return
-38.1%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
-32.4%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
-0.59
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
700.0%
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
3
Buyback Yield
-19.8%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
93
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
95
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
95
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity